Stamenkovic, "The cancer stem cell paradigm in Ewing's sarcoma: what can we learn about these rare cells from a rare tumor?" Expert Review of Anticancer Therapy, vol. 11, no. 2, pp. 143-145, 2011.Riggi, N., Suva, M. L. & Stamenkovic, I. The cancer stem cell paradigm in Ewing...
Ewing's sarcoma: what primary care NPs need to know American Journal for Nurse PractitionersSelby B
Ewing sarcoma is the second most common type ofbone cancerin children but is very rare. It affects about 200 children and young adults every year in the United States. The other risk factors include age between 10 and 20 years, male gender, and previous exposure toradiation therapy. What ar...
Ewing Sarcoma (ES) is mainly diagnosed during the second decade of life. It often compromises the appendicular skeleton but also can affect other bones. A surgical procedure is necessary despite its good response to chemotherapeutics and radiotherapy. When planning limb-sparing procedures for the youn...
Contamination can lead to variety of illnesses, and even death. They can causecancer,hepatic diseases, deterioration of thekidneys,nephropathy, andalimentary toxic aleukia, a potentially fatal illness marked by nausea, vomiting, diarrhea and skin inflammation. They can also impair an animal's immune...
"The cancer stem cell paradigm in Ewing's sarcoma: what can we learn about these rare cells from a rare tumor?" Expert Rev Anticancer Ther 11(2): 143-5.Riggi N, Suva ML, Stamenkovic I (2011) The cancer stem cell paradigm in Ewing's sarcoma: what can we learn about these rare ...
Ewing sarcomaPrimitive neuroectodermal tumorsCranial boneMobile spinePrognosisPrimary Ewing sarcoma (ES)/peripheral primitive neuroectodermal tumors (pPNETs) are aggressive bone tumors that rarely occur in the axial skeleton, including the cranial bone and mobile spine. The purpose of this study was to ...
Twenty years on-what do we really know about Ewing sarcoma and what is the path forward? Crit Rev Oncog 2015; 20: 155-171.Lawlor ER and Sorensen PH (2015) Twenty years on: what do we really know about Ewing sarcoma and what is the path forward? Crit Rev Oncog 20, 155-171....
Patient and methods: This study was a nonrandomized uncontrolled phase II study and was conducted at clinical oncology department and south Egypt cancer institute; it involved 28 patients with histologically confirmed Ewing's sarcoma; all of them were subjected to PET/CT whenever possible or MRI ...
Another differential diagnosis must be considered for an exceptional primitive lung Ewing sarcoma, too [298]. NUT carcinomas express cytokeratins (Figure 2) and P63 but are often negative for neuroendocrine markers and TTF1 [300]. However, some rare tumors can nonetheless be positive for TTF1,...